Riskpilot← Back to searchSign inGet full accessMISSIONPHARMA A/S
A/SActiveCVR 26902398Vassingerødvej 9Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200262 employees
Revenue 2025
DKK 742M
-21% vs 2024
EBITDA margin
12.0%
-39% vs 2024
Equity ratio
67.7%
Financial strength
Net profit 2025
DKK 73,4M
-39% vs 2024
| Revenue | DKK 742M | -21% |
| EBITDA | DKK 89,3M | -39% |
| Net profit | DKK 73,4M | -39% |
| Total assets | DKK 403,2M | -14% |
| Equity | DKK 273,1M | -14% |
| Employees | 62 | — |
Legal name
MISSIONPHARMA A/S
CVR number
26902398
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. december 2002
Share capital
DKK 2.100.000
Employees
62 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening, eller af to direktører i forening, eller af den samlede
bestyrelse
Company purpose
Selskabets formål er at drive handel og industri.
Address
Vassingerødvej 9
Phone
+4548163200
Email
info@missionpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 537.927 | 703.768 | 753.910 | 762.676 | 703.475 | 153.301 | — | 776.981 | 731.472 | 693.959 | 942.492 | 940.120 | 741.955 |
| Staff expenses | -33.422 | -37.222 | -40.728 | -42.962 | -47.471 | -12.505 | -0 | -45.118 | -50.693 | -48.338 | -56.410 | -56.972 | -56.914 |
| EBITDA | 72.144 | 91.859 | 81.413 | 98.904 | 88.793 | 10.303 | — | 35.549 | 120.485 | 73.221 | 157.914 | 145.238 | 89.312 |
| Depreciation & amort. | -3.098 | -1.476 | -444 | -438 | -2.808 | -904 | -0 | -3.636 | -1.999 | -1.590 | -1.550 | -1.415 | -1.365 |
| EBIT | 69.046 | 90.383 | 80.969 | 98.466 | 85.985 | 9.399 | — | 31.913 | 118.486 | 71.631 | 156.364 | 143.823 | 87.947 |
| Net financials | -10.658 | 1.872 | 11.596 | 258 | 7.221 | -5.365 | 0 | -4.437 | -12.025 | 2.041 | -3.375 | 8.347 | 5.169 |
| Profit before tax | 58.388 | 92.254 | 92.565 | 98.724 | 93.206 | 4.034 | — | 27.476 | 106.461 | 73.672 | 152.989 | 152.170 | 93.116 |
| Tax | 14.305 | 23.251 | 18.720 | 20.719 | 17.056 | 656 | -0 | 5.239 | 22.854 | 15.690 | 33.830 | 32.305 | 19.714 |
| Net profit | 44.083 | 69.003 | 73.845 | 78.005 | 76.150 | 3.378 | — | 22.237 | 83.607 | 57.982 | 119.159 | 119.865 | 73.402 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 214.241 | 317.641 | 311.057 | 321.576 | 438.511 | 422.798 | 0 | 380.971 | 427.212 | 428.519 | 538.204 | 470.384 | 403.205 |
| Equity | 124.385 | 162.346 | 185.468 | 209.047 | 284.014 | 286.459 | — | 263.209 | 332.425 | 312.809 | 340.843 | 319.316 | 273.135 |
| Long-term debt | 1.181 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 427 | 0 | 0 |
| Short-term debt | 88.675 | 155.294 | 125.589 | 112.529 | 151.333 | 132.292 | 0 | 114.320 | 91.578 | 113.919 | 196.934 | 141.321 | 117.997 |
| Total debt | 89.856 | 155.294 | 125.589 | 112.529 | 151.333 | 132.292 | 0 | 114.320 | 91.578 | 113.919 | 197.361 | 151.068 | 130.070 |
EBITDA margin
12.0%
This company
15.8%
Market median
-24% vs market
20132025
Equity ratio
67.7%
This company
38.2%
Market median
+77% vs market
20132025
Return on equity
26.9%
This company
18.4%
Market median
+46% vs market
20132025
Net profit margin
9.9%
This company
8.1%
Market median
+22% vs market
20132025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20132025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via CVR / Virk · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via CVR / Virk · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-03-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
PL Management | Management | 2010 | — | — |
AP Management | Management | 2021 | — | — |
ES Management | Management | 2002 | — | — |
CI Management | Management | 2008 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2002 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2004 | — | — | |
| Deputy Chairman | 2012 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 2002 | — | — | |
| Board of Directors | 2002 | — | — | |
| Deputy Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2023 | |
P. GINNERUP ApS | Company | 50.0% | 50.0% | 2003 |
MISSIONPHARMA GROUP ApS | Company | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MISSIONPHARMA A/S 
PHARMADANICA A/SBoard members of MISSIONPHARMA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Monrad Overgaard | Chief Executive Officer | 0 companies |
| Poul Lindof | Management | 0 companies |
| Alexandre Pierre Jean Vialatte | Management | 0 companies |
| Erik Schou Stavnstrup | Management | 0 companies |
| Christian Ilsøe | Management | 0 companies |
| Mikkel Mørkedal Wakefield | Chief Executive Officer | 0 companies |
| Alan Per Binau | Board of Directors | 0 companies |
| Jean-Marc Pierre René Leccia | Chairman | 0 companies |
| Patricia Hec | Board of Directors | 0 companies |
| Henning Brømsøe Termansen | Board of Directors | 0 companies |
| Denis Georges Fernand Maurice | Deputy Chairman | 0 companies |
| Ilona Maureen Fischer | Board of Directors | 0 companies |
| Peter Normann | Board of Directors | 0 companies |
| Eric Pierre Jean Muris | Board of Directors | 0 companies |
| Aymeric Erouart | Board of Directors | 0 companies |
| Jesper Ahlmann Funding Andersen | Board of Directors | 0 companies |
| Leif Ole Lund-Andersen | Chairman | 0 companies |
| Paule Georgette Ginnerup | Board of Directors | 0 companies |
| Kim Erik Ginnerup | Deputy Chairman | 0 companies |
| Annie Renée Simonne Dateu | Board of Directors | 0 companies |